213 related articles for article (PubMed ID: 11111827)
21. Molecular physiology of P2X receptors.
North RA
Physiol Rev; 2002 Oct; 82(4):1013-67. PubMed ID: 12270951
[TBL] [Abstract][Full Text] [Related]
22. Development of fast purinergic transmission in the mouse vas deferens.
Liang SX; D'arbe M; Phillips WD; Lavidis NA
Synapse; 2000 Sep; 37(4):283-91. PubMed ID: 10891865
[TBL] [Abstract][Full Text] [Related]
23. Distribution of P2X receptors in the rat adrenal gland.
Afework M; Burnstock G
Cell Tissue Res; 1999 Dec; 298(3):449-56. PubMed ID: 10639735
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
[TBL] [Abstract][Full Text] [Related]
25. Allosteric modulation of native cochlear P2X receptors: insights from comparison with recombinant P2X2 receptors.
Kanjhan R; Raybould NP; Jagger DJ; Greenwood D; Housley GD
Audiol Neurootol; 2003; 8(3):115-28. PubMed ID: 12679623
[TBL] [Abstract][Full Text] [Related]
26. Activation of P2X(7) receptors stimulates the expression of P2Y(2) receptor mRNA in astrocytes cultured from rat brain.
D'Alimonte I; Ciccarelli R; Di Iorio P; Nargi E; Buccella S; Giuliani P; Rathbone MP; Jiang S; Caciagli F; Ballerini P
Int J Immunopathol Pharmacol; 2007; 20(2):301-16. PubMed ID: 17624242
[TBL] [Abstract][Full Text] [Related]
27. Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel.
Torres GE; Haines WR; Egan TM; Voigt MM
Mol Pharmacol; 1998 Dec; 54(6):989-93. PubMed ID: 9855626
[TBL] [Abstract][Full Text] [Related]
28. Functional expression of ionotropic purinergic receptors on mouse taste bud cells.
Hayato R; Ohtubo Y; Yoshii K
J Physiol; 2007 Oct; 584(Pt 2):473-88. PubMed ID: 17702819
[TBL] [Abstract][Full Text] [Related]
29. P2 receptors in the murine gastrointestinal tract.
Giaroni C; Knight GE; Ruan HZ; Glass R; Bardini M; Lecchini S; Frigo G; Burnstock G
Neuropharmacology; 2002 Dec; 43(8):1313-23. PubMed ID: 12527481
[TBL] [Abstract][Full Text] [Related]
30. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
31. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.
Khakh BS; Burnstock G; Kennedy C; King BF; North RA; Séguéla P; Voigt M; Humphrey PP
Pharmacol Rev; 2001 Mar; 53(1):107-18. PubMed ID: 11171941
[TBL] [Abstract][Full Text] [Related]
32. Expression and localization of P2 nucleotide receptor subtypes during development of the lateral ventricular choroid plexus of the rat.
Johansson PA; Burnstock G; Dziegielewska KM; Guida E; McIntyre P; Saunders NR
Eur J Neurosci; 2007 Jun; 25(11):3319-31. PubMed ID: 17553000
[TBL] [Abstract][Full Text] [Related]
33. P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions.
Musa H; Tellez JO; Chandler NJ; Greener ID; Maczewski M; Mackiewicz U; Beresewicz A; Molenaar P; Boyett MR; Dobrzynski H
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jun; 379(6):541-9. PubMed ID: 19234689
[TBL] [Abstract][Full Text] [Related]
34. Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization.
Gerevich Z; Zadori Z; Müller C; Wirkner K; Schröder W; Rubini P; Illes P
Br J Pharmacol; 2007 May; 151(2):226-36. PubMed ID: 17351651
[TBL] [Abstract][Full Text] [Related]
35. A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors.
Vial C; Rolf MG; Mahaut-Smith MP; Evans RJ
Br J Pharmacol; 2002 Jan; 135(2):363-72. PubMed ID: 11815371
[TBL] [Abstract][Full Text] [Related]
36. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
Köles L; Furst S; Illes P
Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
[TBL] [Abstract][Full Text] [Related]
37. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
[TBL] [Abstract][Full Text] [Related]
38. P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system.
James G; Butt AM
Eur J Pharmacol; 2002 Jul; 447(2-3):247-60. PubMed ID: 12151016
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the involvement of purinergic P2X receptors in outer retinal processing.
Puthussery T; Yee P; Vingrys AJ; Fletcher EL
Eur J Neurosci; 2006 Jul; 24(1):7-19. PubMed ID: 16882003
[TBL] [Abstract][Full Text] [Related]
40. Regional and cellular distribution of the P2Y(1) purinergic receptor in the human brain: striking neuronal localisation.
Moore D; Chambers J; Waldvogel H; Faull R; Emson P
J Comp Neurol; 2000 Jun; 421(3):374-84. PubMed ID: 10813793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
